00:00:00.170 - 00:00:19.820, Speaker A: I realized in the early 2010s that all the innovation that I had wanted to do in biomedicine was blocked by the FDA. And Genomics wasn't simply a technical problem. It wasn't simply a logistical problem. It was a regulatory problem, which meant it was a political problem, which meant it was a sovereignty problem.
